Albert David's Financials Show Mixed Results, But Positive Aspects and Areas of Concern

Despite a flat financial performance in the quarter ending June 2024, Albert David, a microcap pharmaceutical company, has been given a 'Hold' rating by MarketsMOJO. The company's financial score has fallen from 12 to -3 in the last three months.

However, there are some positive aspects to the company's financials. Albert David has shown a strong operating cash flow of Rs 45.50 crore annually in the last three years, indicating higher cash revenues from business operations. The company also has a healthy amount of cash and cash equivalents, with the highest amount of Rs 31.16 crore in the last six half-yearly periods. Additionally, the company has been consistently distributing higher dividends from its profits, with the highest dividend per share of Rs 11.50 in the last five years.

On the other hand, there are some areas of concern in Albert David's financials. The company's profit before tax less other income (PBT) has fallen by -109.04% year on year, with a negative trend in the near term. Similarly, the profit after tax (PAT) has also fallen by -19.8% year on year, with a negative trend in the near term. The company's dividend payout ratio has also decreased each year in the last five years, indicating a lower proportion of profits being distributed as dividends. The operating profit (PBDIT) has also been consistently low in the last five quarters, with a negative trend in the near term. The company's efficiency has also deteriorated, with the lowest operating profit margin of 1.00% in the last five quarters. Additionally, the company's income from non-business activities is high, which may not be a sustainable business model.

In conclusion, while Albert David's financial performance in the quarter ending June 2024 may not be impressive, the company has some positive aspects to its financials. However, there are also some areas of concern that investors should keep in mind while considering their investment in the company.